Different insulin treatment regimens in patient with diabetes mellitus type 1: Effects on quality of life

Background/Aim. Despite of contemporary diabetes mellitus (DM) treatment, one half of patients do not achieve an optimal metabolic control. Considering great psychological burden of diabetic patients, the purpose of this study was to assess the effect of different insulin treatment regimens, glyc...

Full description

Saved in:
Bibliographic Details
Main Authors: Stojanović Jelena, Milošević Dragoslav, Antović Ilija, Sekulić Goran, Beljić-Živković Teodora
Format: Article
Language:English
Published: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2012-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2012/0042-84501200018S.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850243795813138432
author Stojanović Jelena
Milošević Dragoslav
Antović Ilija
Sekulić Goran
Beljić-Živković Teodora
author_facet Stojanović Jelena
Milošević Dragoslav
Antović Ilija
Sekulić Goran
Beljić-Živković Teodora
author_sort Stojanović Jelena
collection DOAJ
description Background/Aim. Despite of contemporary diabetes mellitus (DM) treatment, one half of patients do not achieve an optimal metabolic control. Considering great psychological burden of diabetic patients, the purpose of this study was to assess the effect of different insulin treatment regimens, glycemic control and the presence of vascular complications on self-reported well-being and quality of life (QoL) of subjects with type 1 DM. Methods. The patients with type 1 DM (n = 122) recruited from the outpatient Diabetes Endocrinology Clinic of Zvezdara University Medical Center were divided into 4 groups according to the specific treatment regimen: 26 were on continuous subcutaneous insulin infusion (CSII), 30 on conventional insulin therapy, 33 on multiple daily injections (MDI) with human insulins, and 33 on MDI with insulin analogues. QoL was assessed by self-reported well-being with the following questionnaires: WHO-5 item Well Being Index (WHO- 5), 36 item Short Form (SF-36) survey, and Insulin Treatment Appraisal Scale (ITAS). Objective metabolic control was assessed by glycosylated hemoglobin (HbA1c), lipid levels and the presence of vascular complications. Statistical analyses used in this crosssectional study included: descriptive statistics, Student’s t-test, Chisqare test, contingency tables, ANOVA and correlation methods. Results. The patients on CSII had significantly better metabolic control than all other treatment groups, especially when compared to the one on conventional therapy (CSII HbA1c 7.07 ± 1.48% vs conventional therapy, HbA1c 10.04 ± 1.44; p = 0.000). No significant difference in glycemic control was observed between patients on MDI with human insulins and insulin analogues. Good glycemic control significantly influenced the reported QoL. The patients with retinopathy and nephropathy reported significantly lower physical well-being, and the patients with polyneuropathy and cardiovascular complications reported also lower psychological well being. Conclusions. Insulin treatment regiment selection affects not only objective metabolic control, but also QoL.
format Article
id doaj-art-ae20f11705ec41a9be73486072e7d401
institution OA Journals
issn 0042-8450
language English
publishDate 2012-01-01
publisher Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
record_format Article
series Vojnosanitetski Pregled
spelling doaj-art-ae20f11705ec41a9be73486072e7d4012025-08-20T01:59:53ZengMinistry of Defence of the Republic of Serbia, University of Defence, BelgradeVojnosanitetski Pregled0042-84502012-01-0169756957510.2298/VSP101216018SDifferent insulin treatment regimens in patient with diabetes mellitus type 1: Effects on quality of lifeStojanović JelenaMilošević DragoslavAntović IlijaSekulić GoranBeljić-Živković TeodoraBackground/Aim. Despite of contemporary diabetes mellitus (DM) treatment, one half of patients do not achieve an optimal metabolic control. Considering great psychological burden of diabetic patients, the purpose of this study was to assess the effect of different insulin treatment regimens, glycemic control and the presence of vascular complications on self-reported well-being and quality of life (QoL) of subjects with type 1 DM. Methods. The patients with type 1 DM (n = 122) recruited from the outpatient Diabetes Endocrinology Clinic of Zvezdara University Medical Center were divided into 4 groups according to the specific treatment regimen: 26 were on continuous subcutaneous insulin infusion (CSII), 30 on conventional insulin therapy, 33 on multiple daily injections (MDI) with human insulins, and 33 on MDI with insulin analogues. QoL was assessed by self-reported well-being with the following questionnaires: WHO-5 item Well Being Index (WHO- 5), 36 item Short Form (SF-36) survey, and Insulin Treatment Appraisal Scale (ITAS). Objective metabolic control was assessed by glycosylated hemoglobin (HbA1c), lipid levels and the presence of vascular complications. Statistical analyses used in this crosssectional study included: descriptive statistics, Student’s t-test, Chisqare test, contingency tables, ANOVA and correlation methods. Results. The patients on CSII had significantly better metabolic control than all other treatment groups, especially when compared to the one on conventional therapy (CSII HbA1c 7.07 ± 1.48% vs conventional therapy, HbA1c 10.04 ± 1.44; p = 0.000). No significant difference in glycemic control was observed between patients on MDI with human insulins and insulin analogues. Good glycemic control significantly influenced the reported QoL. The patients with retinopathy and nephropathy reported significantly lower physical well-being, and the patients with polyneuropathy and cardiovascular complications reported also lower psychological well being. Conclusions. Insulin treatment regiment selection affects not only objective metabolic control, but also QoL.http://www.doiserbia.nb.rs/img/doi/0042-8450/2012/0042-84501200018S.pdfdiabetes mellitus, type 1therapeuticsquality of lifequestionnaires
spellingShingle Stojanović Jelena
Milošević Dragoslav
Antović Ilija
Sekulić Goran
Beljić-Živković Teodora
Different insulin treatment regimens in patient with diabetes mellitus type 1: Effects on quality of life
Vojnosanitetski Pregled
diabetes mellitus, type 1
therapeutics
quality of life
questionnaires
title Different insulin treatment regimens in patient with diabetes mellitus type 1: Effects on quality of life
title_full Different insulin treatment regimens in patient with diabetes mellitus type 1: Effects on quality of life
title_fullStr Different insulin treatment regimens in patient with diabetes mellitus type 1: Effects on quality of life
title_full_unstemmed Different insulin treatment regimens in patient with diabetes mellitus type 1: Effects on quality of life
title_short Different insulin treatment regimens in patient with diabetes mellitus type 1: Effects on quality of life
title_sort different insulin treatment regimens in patient with diabetes mellitus type 1 effects on quality of life
topic diabetes mellitus, type 1
therapeutics
quality of life
questionnaires
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2012/0042-84501200018S.pdf
work_keys_str_mv AT stojanovicjelena differentinsulintreatmentregimensinpatientwithdiabetesmellitustype1effectsonqualityoflife
AT milosevicdragoslav differentinsulintreatmentregimensinpatientwithdiabetesmellitustype1effectsonqualityoflife
AT antovicilija differentinsulintreatmentregimensinpatientwithdiabetesmellitustype1effectsonqualityoflife
AT sekulicgoran differentinsulintreatmentregimensinpatientwithdiabetesmellitustype1effectsonqualityoflife
AT beljiczivkovicteodora differentinsulintreatmentregimensinpatientwithdiabetesmellitustype1effectsonqualityoflife